血管内超音波法（IVUS）市場報告書：2011年版 是由出版商Koncept Analytics在2011年05月所出版的。
這份英文市場調查報告書包含33 pages 價格從美金800起跳。
血管内超音波法（IVUS）主要用於以高周波音波由内部觀察冠狀動脈。醫療領域的IVUS技術貢獻了很大的幫助，也讓IVUS市場完成了至今的成長。使用度是上升，但IVUS技術還未達到全球性的浸透。IVUS業界的主要課題之一是其價格的高漲與償還施設不足。費用效果比的高度治療需求，也對IVUS技術的使用造成負面影響。
本報告書為全球IVUS市場之分析，市場現狀與日本、美國、歐洲各地區市場動向、大企業簡介與商業戰略等整理，概述如下。
第1章 IVUS：導論
第2章 全球IVUS市場
第3章 各地區市場
第4章 成長促進因子
- PCI處置的低浸透度
- 研究中IVUS的使用擴大
- PCI與支架處置的增加
- 世界的恒例化
第5章 主要問題與課題
第6章 競爭環境
第7章 企業簡介
- Volcano Corporation
- Boston Scientific Corporation
- Terumo股份有限公司
Abstract
IVUS, which stands for Intravascular Ultrasound, is primarily used to view the
coronary arteries from inside, with the help of high frequency sound waves.
The primary use of IVUS is during Percutaneous Coronary Intervention (PCI) or
angioplasty, as it provides a better understanding of blocked vessels, which
allows for proper selection and placement of stents and other devices to
restore blood flow at the site of the blockage. In fact, after stenting, the
IVUS procedures are used to determine whether the stent has been placed
correctly or not and thereby it helps to place the stent optimally and thereby
reducing the need for re-stenosis. The IVUS procedures are generally performed
in the catheterization laboratories or cath-labs.
Owing to the benefits provided by the IVUS technology in the medical field,
the IVUS market has shown increasing growth in the past years. Despite
increase in usage, the IVUS technology is still under penetrated worldwide,
one of the main reasons for this being the fact that the reimbursement
criteria for the IVUS is not flexible and the insurers do not generally
reimburse the IVUS procedures. In Japan, where IVUS reimbursement criteria are
flexible, the technology has high penetration rates and IVUS procedures are
accompanied with a majority of the PCI procedures. The second largest market
for IVUS in terms of usage is the US, followed by Europe. With the
introduction of IVUS in the emerging countries, coupled with the increasing
consumer income, increasing health awareness among the people and favoring
demographics, such countries are expected to drive the IVUS market in coming
years.
Low penetration of IVUS into the PCI procedures, increasing PCI and stent
procedures, increasing risks of cardiovascular diseases, and ageing population
are some of the factors which are likely to be responsible for the growth of
IVUS market in future.
One of the major issues in the IVUS industry is its high pricing and lack of
reimbursement facilities. This factor, coupled with the need for a cost
effective medical treatment, are likely to negatively impact the use of IVUS
technology. Also, the IVUS industry is highly regulated. IVUS industry is also
facing a possible threat from the introduction of an almost similar procedure,
OCT (or Optical Coherence Tomography), which is a medical imaging technique
used to view the entire vessel wall. OCT has certain advantages over IVUS, one
of the important ones include that OCT can determine the accurate depth of the
plaque, whereas IVUS can not.
In association with analyzing the global IVUS market, the current report also
discusses the major regional markets, including Japan, US, and Europe. The
report delves into the factors impacting the industry. The profiles of Volcano
Corporation, Boston Scientific, and Terumo Corporation are also being
presented in the report, with a discussion of their business strategies.
Table of Contents
1. IVUS-An Introduction
2. Global IVUS Market
- Market Value
- Market Volume
- Geographic Breakdown
3. Regional Analysis
- 3.1 Japan
- IVUS Procedure
- PCI Procedures
- IVUS Penetration
- 3.2 The US
- IVUS Procedure
- PCI Procedures
- IVUS Penetration
- 3.3 Europe
- IVUS Procedure
- PCI Procedures
- IVUS Penetration
- 3.4 India-An Emerging Market
4. Growth Drivers
- 4.1 Low Penetration into PCI Procedures
- 4.2 Increasing Use of IVUS in Research
- 4.3 Increasing PCI and Stent Procedures
- 4.5 Ageing Population Worldwide
5. Key Issues and Challenges
- 5.1 Stringent Regulations
- 5.2 Lack of Reimbursement
- 5.3 Possible Threat from OCT Procedures
6. Competitive Landscape
- Global Market
- United States
- Europe
- Japan
7. Company Profiles
- Company Overview
- Key Financials
- Business Strategies
- Grow Existing IVUS and FM Markets Globally
- Expansion into New Markets
- Growth through Acquisitions and Collaborations
- 7.2 Boston Scientific Corporation
- Company Overview
- Key Financials
- Business Strategies
- Realign the Business Portfolio
- Business Restructuring Initiatives
- Company Overview
- Key Financials
- Business Strategies
- Focus on Research and Development
- Launching New and Innovative Products
List of Tables/Charts
- Worldwide Vascular Imaging Market (2008-2012E)
- Global IVUS Procedures (2007-2013E)
- Global IVUS Market (2007-2010E)
- Global IVUS Procedures-Share by Regions (2009)
- Japanese IVUS Procedures (2007-2013E)
- PCI Procedures in Japan (2005-2012E)
- IVUS Penetration into PCI Population in Japan (2007-2013E)
- US IVUS Procedures (2007-2013E)
- PCI Procedures in the US (2005-2013E)
- IVUS Penetration into PCI Population in the US (2007-2013E)
- European IVUS Procedures (2007-2013E)
- PCI Procedures in Europe (2005-2013E)
- IVUS Penetration into PCI Population in Europe (2007-2013E)
- IVUS Penetration into PCI Procedures Worldwide (2007-2012E)
- Global PCI Procedures (2007-2013E)
- Global Stent Market Growth, 2000-2009
- Ageing Population Worldwide (age>65) 2005-2015
- Global IVUS Market-Share by Companies (2010E)
- Japanese IVUS Market-Share by Companies (2010E)
- European IVUS Market-Share by Companies (2010E)
- US IVUS Market-Share by Companies (2010E)
- Volcano Corporation Revenue (2006-2010)
- Volcano Corporation Revenue-Share by Business Segments (FY10)
- Volcano Corporation Revenue-Share by Regions (FY10)
- Boston Scientific Revenue (2006-2010)
- Boston Scientific Revenue-Share by Segments (2010)
- Boston Scientific Revenue-Share by Regions (2010)
- Terumo Corporation Revenue (FY06-FY10)
- Terumo Corporation Revenue-Share by Business Segments (FY10)
- Terumo Corporation Revenue-Share by Regions (FY10)
- Use of IVUS Pre- and Post-PCI
